1. Home
  2. ABT vs AZN Comparison

ABT vs AZN Comparison

Compare ABT & AZN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

ABT

Abbott Laboratories

HOLD

Current Price

$110.73

Market Cap

152.9B

Sector

Health Care

ML Signal

HOLD

Logo AstraZeneca PLC

AZN

AstraZeneca PLC

HOLD

Current Price

$157.67

Market Cap

316.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ABT
AZN
Founded
1888
1992
Country
United States
United Kingdom
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
152.9B
316.4B
IPO Year
2006
1995

Fundamental Metrics

Financial Performance
Metric
ABT
AZN
Price
$110.73
$157.67
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
20
1
Target Price
$130.90
N/A
AVG Volume (30 Days)
8.6M
3.7M
Earning Date
04-16-2026
04-29-2026
Dividend Yield
2.76%
1.73%
EPS Growth
N/A
N/A
EPS
0.61
N/A
Revenue
$44,328,000,000.00
N/A
Revenue This Year
$10.75
$10.34
Revenue Next Year
$8.10
$6.43
P/E Ratio
$181.84
$31.91
Revenue Growth
5.67
N/A
52 Week Low
$81.97
$72.90
52 Week High
$137.49
$212.71

Technical Indicators

Market Signals
Indicator
ABT
AZN
Relative Strength Index (RSI) 71.95 35.79
Support Level $105.27 $153.41
Resistance Level $111.89 $175.04
Average True Range (ATR) 2.54 3.15
MACD 0.15 -0.30
Stochastic Oscillator 82.78 19.87

Price Performance

Historical Comparison
ABT
AZN

About ABT Abbott Laboratories

Abbott manufactures and markets cardiovascular and diabetes devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, continuous glucose monitors, and immunoassays and point-of-care diagnostic equipment. Abbott derives roughly 60% of sales outside the United States.

About AZN AstraZeneca PLC

A merger between Astra of Sweden and Zeneca of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across a number of major therapeutic areas, including oncology (over 40% of total revenue), cardiovascular, renal, and metabolic (over 20%), rare disease (16%), and respiratory and immunology (15%). The majority of sales comes from international markets, with the United States representing close to one-third of its sales.

Share on Social Networks: